ArticleBritish journal of pharmacology2021

A drug screen with approved compounds identifies amlexanox as a novel Wnt/β-catenin activator inducing lung epithelial organoid formation.

Rita Costa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.